| Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes L Zhu, ZG She, X Cheng, JJ Qin, XJ Zhang, J Cai, F Lei, H Wang, J Xie, ... Cell metabolism 31 (6), 1068-1077. e3, 2020 | 1821 | 2020 |
| Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with … P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ... Circulation research 126 (12), 1671-1681, 2020 | 1319 | 2020 |
| Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta‐analysis F Zhou, J Zhou, W Wang, XJ Zhang, YX Ji, P Zhang, ZG She, L Zhu, J Cai, ... Hepatology 70 (4), 1119-1133, 2019 | 532 | 2019 |
| Epidemiological features of NAFLD from 1999 to 2018 in China J Zhou, F Zhou, W Wang, XJ Zhang, YX Ji, P Zhang, ZG She, L Zhu, J Cai, ... Hepatology 71 (5), 1851-1864, 2020 | 482 | 2020 |
| Longitudinal association between markers of liver injury and mortality in COVID‐19 in China F Lei, YM Liu, F Zhou, JJ Qin, P Zhang, L Zhu, XJ Zhang, J Cai, L Lin, ... Hepatology 72 (2), 389-398, 2020 | 470 | 2020 |
| Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19 JJ Qin, XU Cheng, F Zhou, F Lei, G Akolkar, J Cai, XJ Zhang, A Blet, J Xie, ... Hypertension 76 (4), 1104-1112, 2020 | 176 | 2020 |
| Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes X Cheng, YM Liu, H Li, X Zhang, F Lei, JJ Qin, Z Chen, KQ Deng, L Lin, ... Cell metabolism 32 (4), 537-547. e3, 2020 | 158 | 2020 |
| Interferon regulatory factor 3 constrains IKKβ/NF‐κB signaling to alleviate hepatic steatosis and insulin resistance XA Wang, R Zhang, ZG She, XF Zhang, DS Jiang, T Wang, L Gao, ... Hepatology 59 (3), 870-885, 2014 | 153 | 2014 |
| Perioperative presentation of COVID‐19 disease in a liver transplant recipient J Qin, H Wang, X Qin, P Zhang, L Zhu, J Cai, Y Yuan, H Li Hepatology 72 (4), 1491-1493, 2020 | 134 | 2020 |
| Baicalein, a natural product, selectively activating AMPKα2 and ameliorates metabolic disorder in diet-induced mice P Pu, XA Wang, M Salim, LH Zhu, L Wang, JF Xiao, W Deng, HW Shi, ... Molecular and cellular endocrinology 362 (1-2), 128-138, 2012 | 134 | 2012 |
| Low-dose sorafenib acts as a mitochondrial uncoupler and ameliorates nonalcoholic steatohepatitis C Jian, J Fu, XU Cheng, LJ Shen, YX Ji, X Wang, S Pan, H Tian, S Tian, ... Cell Metabolism 31 (5), 892-908. e11, 2020 | 125 | 2020 |
| Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways C Liu, F Cao, QZ Tang, L Yan, YG Dong, LH Zhu, L Wang, ZY Bian, H Li The Journal of nutritional biochemistry 21 (12), 1238-1250, 2010 | 116 | 2010 |
| The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19 J Cai, H Li, C Zhang, Z Chen, H Liu, F Lei, JJ Qin, YM Liu, F Zhou, X Song, ... Cell metabolism 33 (2), 258-269. e3, 2021 | 115 | 2021 |
| Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease W Wang, M Hu, H Liu, X Zhang, H Li, F Zhou, YM Liu, F Lei, JJ Qin, ... Cell metabolism 33 (10), 1943-1956. e2, 2021 | 94 | 2021 |
| Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCβ2/Rac1-dependent signaling LH Zhu, L Wang, D Wang, H Jiang, QZ Tang, L Yan, ZY Bian, XA Wang, ... Free Radical Biology and Medicine 48 (4), 471-482, 2010 | 94 | 2010 |
| Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice XA Wang, R Zhang, D Jiang, W Deng, S Zhang, S Deng, J Zhong, T Wang, ... Hepatology 58 (2), 603-616, 2013 | 88 | 2013 |
| Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury PX Wang, R Zhang, L Huang, LH Zhu, DS Jiang, HZ Chen, Y Zhang, ... Journal of hepatology 62 (1), 111-120, 2015 | 82 | 2015 |
| Dickkopf-3 attenuates pressure overload-induced cardiac remodelling Y Zhang, Y Liu, XH Zhu, XD Zhang, DS Jiang, ZY Bian, XF Zhang, K Chen, ... Cardiovascular research 102 (1), 35-45, 2014 | 81 | 2014 |
| Ubiquitin‐specific peptidase 10 (USP10) inhibits hepatic steatosis, insulin resistance, and inflammation through Sirt6 P Luo, C Qin, L Zhu, C Fang, Y Zhang, H Zhang, F Pei, S Tian, XY Zhu, ... Hepatology 68 (5), 1786-1803, 2018 | 79 | 2018 |
| LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling ZY Bian, H Huang, H Jiang, DF Shen, L Yan, LH Zhu, L Wang, F Cao, ... Hypertension 55 (2), 257-263, 2010 | 79 | 2010 |
